Pamplona looks to exit Parexel via Evercore

The contract research organization weighs its options as industry valuations prove robust, with Thermo Fisher buying PE-backed PPD at a more than 20x EBITDA multiple last week.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this